Active RA is dominated by MerTK-negative (MerTK−) macrophages secreting pro-inflammatory cytokines, while remission phases enrich MerTK-positive (MerTK+) macrophages with repair functions (93). The gene discussed is MERTK; the disease is rheumatoid arthritis.